94 related articles for article (PubMed ID: 16887436)
21. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
22. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study.
Celik O; Sahin I; Celik N; Hascalik S; Keskin L; Ozcan H; Uckan A; Kosar F
Hum Reprod; 2007 Nov; 22(11):2992-8. PubMed ID: 17855407
[TBL] [Abstract][Full Text] [Related]
24. Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.
Lechner E; Schreier-Lechner EM; Hofer A; Gitter R; Mair R; Biebl A; Tulzer G
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):560-4. PubMed ID: 19698835
[TBL] [Abstract][Full Text] [Related]
25. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
[TBL] [Abstract][Full Text] [Related]
26. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
27. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease.
Grasso S; Leone A; De Michele M; Anaclerio R; Cafarelli A; Ancona G; Stripoli T; Bruno F; Pugliese P; Dambrosio M; Dalfino L; Di Serio F; Fiore T
Crit Care Med; 2007 Jan; 35(1):96-105. PubMed ID: 17095948
[TBL] [Abstract][Full Text] [Related]
28. NT-proBNP in monitoring treatment of patients with congestive heart failure.
Al-Meslmani BM; Fahoum SK; Shamia MG
Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
[TBL] [Abstract][Full Text] [Related]
29. Correlation Between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study.
Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Thanapiboonpol P; Nakyen S; Udompunturak S
J Card Fail; 2008 Oct; 14(8):687-94. PubMed ID: 18926441
[TBL] [Abstract][Full Text] [Related]
30. [Usefulness of NT-ProBNP as a biomarker of clinical status in outpatients with chronic heart failure].
Casado JM; Díaz A; Suárez C
Rev Esp Cardiol; 2008 Feb; 61(2):206-10. PubMed ID: 18364191
[TBL] [Abstract][Full Text] [Related]
31. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
[TBL] [Abstract][Full Text] [Related]
33. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients.
Ilea M; Zdrenghea D; Bodisz G; Mălai A; Gheorghiu L; Predescu D; Beudean M; Ossian V; Gligor E; Vlad C; Pop D; Bogdan E; Roşu R
Rom J Intern Med; 2008; 46(1):63-8. PubMed ID: 19157272
[TBL] [Abstract][Full Text] [Related]
34. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure.
Schou M; Gustafsson F; Corell P; Kistorp CN; Kjaer A; Hildebrandt PR
Am Heart J; 2007 Jul; 154(1):123-9. PubMed ID: 17584564
[TBL] [Abstract][Full Text] [Related]
35. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
[TBL] [Abstract][Full Text] [Related]
36. Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction.
Goetze JP; Mogelvang R; Maage L; Scharling H; Schnohr P; Sogaard P; Rehfeld JF; Jensen JS
Eur Heart J; 2006 Dec; 27(24):3004-10. PubMed ID: 17118955
[TBL] [Abstract][Full Text] [Related]
37. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
38. NT-proBNP, IGF-I and survival in patients with chronic heart failure.
Petretta M; Colao A; Sardu C; Scopacasa F; Marzullo P; Pivonello R; Fontanella L; de Caterina M; de Simone A; Bonaduce D
Growth Horm IGF Res; 2007 Aug; 17(4):288-96. PubMed ID: 17383209
[TBL] [Abstract][Full Text] [Related]
39. Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width.
Goode KM; Clark AL; Cleland JG
Int J Cardiol; 2008 Nov; 130(3):426-37. PubMed ID: 18178273
[TBL] [Abstract][Full Text] [Related]
40. Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency.
Wallaschofski H; Saller B; Spilcke-Liss E; Lerch MM; Lohmann T; Eigenthaler M
Horm Metab Res; 2006 Oct; 38(10):656-61. PubMed ID: 17075774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]